Premium
Basal‐IQ technology in the real world: satisfaction and reduction of diabetes burden in individuals with type 1 diabetes
Author(s) -
Messer L. H.,
Campbell K.,
Pyle L.,
Forlenza G. P.
Publication year - 2021
Publication title -
diabetic medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.474
H-Index - 145
eISSN - 1464-5491
pISSN - 0742-3071
DOI - 10.1111/dme.14381
Subject(s) - medicine , diabetes mellitus , basal (medicine) , type 2 diabetes , type 1 diabetes , patient satisfaction , physical therapy , endocrinology , surgery
Aim To describe person‐reported outcomes of the Basal‐IQ predictive low‐glucose‐suspend system (Tandem Diabetes Care, San Diego, CA, USA) in real‐world use. Methods Adults with type 1 diabetes/caregivers of minors with type 1 diabetes completed the Diabetes Impact and Device Satisfaction questionnaire (11 items scored on 10‐point Likert scales) prior to Basal‐IQ system initiation, and at 2, 4 and 6 months post‐initiation. Analysis was stratified by previous insulin treatment method. Beta mixed models were used to measure change in device satisfaction (e.g. trust, ease of use) and diabetes impact (e.g. hypoglycaemia fear, poor sleep) scores between time points, adjusting for baseline covariates. Results A total of 967 adults and caregivers [54% women, mean ( sd ) age 36 (17) years, 57% Tandem pump users, 27% non‐Tandem pump users, 17% multiple daily injection users] completed surveys. Device satisfaction significantly increased from baseline to 2 months in all groups ( P <0.001 multiple daily injection and non‐Tandem pump users; P =0.048 Tandem pump users), and was sustained from 2 to 6 months in all groups. Diabetes impact decreased significantly from baseline to 2 months in all groups ( P <0.001 for all), was sustained from 2 to 6 months in multiple daily injection and Tandem pump users, and increased slightly at 4 months/decreased at 6 months in non‐Tandem users. Conclusion The Basal‐IQ system increased device satisfaction and reduced diabetes impact in all users in the first 2 months of use, and satisfaction was sustained over 6 months, with small fluctuations.